10x Genomics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
/ 
Frequently asked questions
To buy 10x Genomics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for 10x Genomics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for 10x Genomics Inc. is TXG:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
10x Genomics Inc. has its primary listing on NASDAQ. You can trade 10x Genomics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, 10x Genomics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include 10x Genomics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like 10x Genomics Inc..